Global burden of vaccine-associated anaphylaxis and their related vaccines, 1967-2023: A comprehensive analysis of the international pharmacovigilance database.

Kyeonghun LeeHayeon LeeRosie KwonYoun Ho ShinSeung Geun YeoYoung Joo LeeMin Seo KimYong Sung ChoiPapadopoulos G NikolaosMasoud RahmatiJunyang JungJinseok LeeDong-Keon Yon

Published in: Allergy (2023)

Although multiple vaccines are associated with various spectra and risks of anaphylaxis, clinicians should recognize the possibility of anaphylaxis occurring with all vaccines, particularly the COVID-19 mRNA and inactivated whole-virus COVID-19 vaccines, and consider the risk factors associated with vaccine anaphylaxis reports. Further studies are warranted to identify better ways of preventing vaccine-associated anaphylaxis.

Keyphrases

coronavirus disease
sars cov
adverse drug
emergency department
respiratory syndrome coronavirus
risk factors
drug induced
risk assessment
binding protein